Literature DB >> 11877449

A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5.

Nico Ghilardi1, Ji Li, Jo-Anne Hongo, Sothy Yi, Austin Gurney, Frederic J de Sauvage.   

Abstract

Here we report the cloning of a novel type I cytokine receptor, gp130-like monocyte receptor (GLM-R), with homology to the interleukin-6 receptor signal transducing chain, gp130, and granulocyte colony-stimulating factor receptor. Human and murine GLM-R cDNAs encode open reading frames of 732 and 716 amino acids, respectively, and the corresponding genes are located in close proximity to gp130 genes on human chromosome 5 and mouse chromosome 13. GLM-R is specifically expressed on CD14-positive cells and is up-regulated more than 50-fold upon activation of those cells. To address the question of whether GLM-R is a signaling receptor, we constructed a chimeric molecule, consisting of the extracellular domain of human growth hormone (hGH) receptor, and the intracellular domain of GLM-R. When transfected into factor-dependent 32D cells, this chimeric molecule could signal for proliferation and activate signal transducer and activator of transcription (STAT)-3 and STAT-5 upon stimulation with hGH. Thus, GLM-R is a novel signaling receptor chain potentially involved in the development and function of monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877449     DOI: 10.1074/jbc.M201140200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Definition and characterization of an inhibitor for interleukin-31.

Authors:  Emilie Venereau; Caroline Diveu; Linda Grimaud; Elisa Ravon; Josy Froger; Laurence Preisser; Yannic Danger; Mike Maillasson; Laure Garrigue-Antar; Yannick Jacques; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

Authors:  Hilary F Clark; Austin L Gurney; Evangeline Abaya; Kevin Baker; Daryl Baldwin; Jennifer Brush; Jian Chen; Bernard Chow; Clarissa Chui; Craig Crowley; Bridget Currell; Bethanne Deuel; Patrick Dowd; Dan Eaton; Jessica Foster; Christopher Grimaldi; Qimin Gu; Philip E Hass; Sherry Heldens; Arthur Huang; Hok Seon Kim; Laura Klimowski; Yisheng Jin; Stephanie Johnson; James Lee; Lhney Lewis; Dongzhou Liao; Melanie Mark; Edward Robbie; Celina Sanchez; Jill Schoenfeld; Somasekar Seshagiri; Laura Simmons; Jennifer Singh; Victoria Smith; Jeremy Stinson; Alicia Vagts; Richard Vandlen; Colin Watanabe; David Wieand; Kathryn Woods; Ming-Hong Xie; Daniel Yansura; Sothy Yi; Guoying Yu; Jean Yuan; Min Zhang; Zemin Zhang; Audrey Goddard; William I Wood; Paul Godowski; Alane Gray
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

3.  Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31.

Authors:  Hal E Broxmeyer; Ji Li; Giao Hangoc; Scott Cooper; Wen Tao; Charlie Mantel; Barbara Graham-Evans; Nico Ghilardi; Frederic J de Sauvage
Journal:  Exp Hematol       Date:  2007-04       Impact factor: 3.084

Review 4.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

5.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

Authors:  Javeed Iqbal; Dennis D Weisenburger; Timothy C Greiner; Julie M Vose; Timothy McKeithan; Can Kucuk; Huimin Geng; Karen Deffenbacher; Lynette Smith; Karen Dybkaer; Shigeo Nakamura; Masao Seto; Jan Delabie; Francoise Berger; Florence Loong; Wing Y Au; Young-Hyeh Ko; Ivy Sng; James Olen Armitage; Wing C Chan
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

6.  Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB.

Authors:  Samantha Leong; Yue Zhao; Rodrigo Ribeiro-Rodrigues; Edward C Jones-López; Carlos Acuña-Villaorduña; Patricia Marques Rodrigues; Moises Palaci; David Alland; Reynaldo Dietze; Jerrold J Ellner; W Evan Johnson; Padmini Salgame
Journal:  Tuberculosis (Edinb)       Date:  2020-01-07       Impact factor: 3.131

7.  Characterization of a potent human interleukin-11 agonist.

Authors:  Dimitri Harmegnies; Xiao-Ming Wang; Paul Vandenbussche; Arnaud Leon; Patricia Vusio; Joachim Grötzinger; Yannick Jacques; Erik Goormaghtigh; Bart Devreese; Jean Content
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

8.  Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.

Authors:  Sabine Le Saux; François Rousseau; Fabien Barbier; Elisa Ravon; Linda Grimaud; Yannic Danger; Josy Froger; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

Review 9.  Structures and biological functions of IL-31 and IL-31 receptors.

Authors:  Qing Zhang; Prabhakar Putheti; Qiang Zhou; Quansheng Liu; Wenda Gao
Journal:  Cytokine Growth Factor Rev       Date:  2008-10-15       Impact factor: 7.638

10.  The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Authors:  E Ferretti; C Tripodo; G Pagnan; C Guarnotta; D Marimpietri; M V Corrias; D Ribatti; S Zupo; G Fraternali-Orcioni; J L Ravetti; V Pistoia; A Corcione
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.